LENSAR (LNSR) Stock Overview
A commercial-stage medical device company, focuses on designing, developing, and marketing laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
LNSR Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
LENSAR, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$12.16 |
| 52 Week High | US$17.31 |
| 52 Week Low | US$5.52 |
| Beta | 0.65 |
| 1 Month Change | -0.25% |
| 3 Month Change | -6.68% |
| 1 Year Change | 110.02% |
| 3 Year Change | 170.22% |
| 5 Year Change | 26.67% |
| Change since IPO | 35.11% |
Recent News & Updates
Recent updates
Global System Placements Will Improve Operating Room Efficiency
Strong system placements and contract pipelines in international markets enhance potential for sustained revenue growth and competitive advantage.Even With A 28% Surge, Cautious Investors Are Not Rewarding LENSAR, Inc.'s (NASDAQ:LNSR) Performance Completely
Jan 28
We're Hopeful That LENSAR (NASDAQ:LNSR) Will Use Its Cash Wisely
Dec 24Market Might Still Lack Some Conviction On LENSAR, Inc. (NASDAQ:LNSR) Even After 28% Share Price Boost
Oct 24LENSAR (NASDAQ:LNSR) Is In A Good Position To Deliver On Growth Plans
Sep 12LENSAR, Inc. (NASDAQ:LNSR) Doing What It Can To Lift Shares
Jul 16Here's Why Shareholders May Want To Be Cautious With Increasing LENSAR, Inc.'s (NASDAQ:LNSR) CEO Pay Packet
May 01LENSAR, Inc.'s (NASDAQ:LNSR) Shares Leap 33% Yet They're Still Not Telling The Full Story
Feb 22Here's Why We're Watching LENSAR's (NASDAQ:LNSR) Cash Burn Situation
Jan 24Not Many Are Piling Into LENSAR, Inc. (NASDAQ:LNSR) Just Yet
Dec 20Here's Why We're A Bit Worried About LENSAR's (NASDAQ:LNSR) Cash Burn Situation
Oct 21Investors Continue Waiting On Sidelines For LENSAR, Inc. (NASDAQ:LNSR)
Sep 13This Broker Just Slashed Their LENSAR, Inc. (NASDAQ:LNSR) Earnings Forecasts
Mar 21Will LENSAR (NASDAQ:LNSR) Spend Its Cash Wisely?
Mar 18Here's Why We're Not Too Worried About LENSAR's (NASDAQ:LNSR) Cash Burn Situation
Nov 01LENSAR GAAP EPS of -$0.67, revenue of $8M
Aug 08LENSAR (NASDAQ:LNSR) Is In A Good Position To Deliver On Growth Plans
Mar 23We Think LENSAR (NASDAQ:LNSR) Can Afford To Drive Business Growth
Jul 28What You Need To Know About LENSAR, Inc.'s (NASDAQ:LNSR) Investor Composition
Feb 25We're Keeping An Eye On LENSAR's (NASDAQ:LNSR) Cash Burn Rate
Jan 03Shareholder Returns
| LNSR | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 2.4% | -1.5% | -2.1% |
| 1Y | 110.0% | -0.3% | 17.2% |
Return vs Industry: LNSR exceeded the US Medical Equipment industry which returned -0.3% over the past year.
Return vs Market: LNSR exceeded the US Market which returned 20.1% over the past year.
Price Volatility
| LNSR volatility | |
|---|---|
| LNSR Average Weekly Movement | 3.5% |
| Medical Equipment Industry Average Movement | 8.4% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in US Market | 17.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: LNSR has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: LNSR's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 140 | Nick Curtis | www.lensar.com |
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System. The company offers LENSAR Laser System which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room.
LENSAR, Inc. Fundamentals Summary
| LNSR fundamental statistics | |
|---|---|
| Market cap | US$149.18m |
| Earnings (TTM) | -US$49.31m |
| Revenue (TTM) | US$58.36m |
Is LNSR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LNSR income statement (TTM) | |
|---|---|
| Revenue | US$58.36m |
| Cost of Revenue | US$30.84m |
| Gross Profit | US$27.52m |
| Other Expenses | US$76.84m |
| Earnings | -US$49.31m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -4.13 |
| Gross Margin | 47.16% |
| Net Profit Margin | -84.49% |
| Debt/Equity Ratio | 0% |
How did LNSR perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/04 18:51 |
| End of Day Share Price | 2025/11/04 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
LENSAR, Inc. is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Gorman | BTIG |
| Frank Takkinen | Lake Street Capital Markets, LLC |
| Richard Newitter | Leerink Partners LLC |